FDA Inspection 1162932 — Robert J. Kreitman, MD

Robert J. Kreitman, MD — FEI 3003786134

The FDA completed an inspection of Robert J. Kreitman, MD on Feb 3, 2022 in Bethesda, MD. The inspection was classified NAI (No Action Indicated — no objectionable conditions or practices were found during the inspection). Product area: Drugs.

Inspection Details

Classification
No Action Indicated (NAI)
End Date
Feb 3, 2022
Fiscal Year
2022
Product Type
Drugs
Project Area
Bioresearch Monitoring
Location
Bethesda, MD (United States)

Additional Details

Clinical Investigator (CI)